Objective: To investigate the safety and effectiveness of augmenting physiotherapy with family-assisted therapy, to inform a future, fully powered trial. Design: Parallel pilot randomized controlled trial. Setting: Transition Care Program. Participants: Thirty-five older adults with multimorbidity, recently hospitalized, with a mean age of 84.1 years (SD = 6.1 years) and mean Modified Barthel Index of 67.8 units (SD = 19.2 units), and 40 family members. Interventions: The control group (n = 18) received usual physiotherapy care. The experimental group (n = 17) received usual physiotherapy care and family-assisted therapy from a family member trained by a physiotherapist. Main measures: Primary outcomes were falls-related self-efficacy measured by the Short Falls Efficacy Scale -International and falls during the intervention period. Secondary outcomes included daily steps, EQ-5D-3L (three-level version of the EuroQoL five-dimensional health-related quality of life questionnaire) and ICECAP-O (ICEpop CAPability measure for Older people), Modified Barthel Index and Modified Caregiver Strain Index. Results: There were no between-group differences for falls-related self-efficacy. Relative to the control group, the experimental group was observed to have a reduced risk of falling (relative risk = 0.38, 95% confidence interval (CI) = 0.09-1.60) and a reduced falls rate (incidence rate ratio = 0.22, 95% CI = 0.04-1.20) was of borderline statistical significance. The experimental group walked a mean of 944 daily steps more than the control group (95% CI = 139-1748) and had a significant reduction in activity limitation. There were no between-group differences for quality of life or caregiver strain. Conclusion: Augmenting physiotherapy with family-assisted therapy is feasible for older people transitioning from hospital to the community. A fully powered randomized controlled trial is indicated.
Introduction
The hazards of hospitalization, including bed rest and injurious falls, can make transitioning home difficult for older adults with multimorbidity. [1] [2] [3] Programmes such as Transition Care in Australia 4 and Intermediate Care in the United Kingdom 5 aim to support older people with time and therapy to facilitate their return to community living. Physiotherapy can facilitate recovery of physical function 6 but the amount of therapy received by patients in transitional programmes is often low. 7 Family-assisted therapy may augment physiotherapy for older people in transitional programmes. A systematic review found allied health therapy provided by families can improve outcomes but most trials investigated parent-led speech pathology interventions for children. 8 A Cochrane review of six studies (333 participants) found very low to moderate-quality evidence that caregiver-mediated exercise may improve outcomes for people after stroke (mean age = 60 years). 9 The largest randomized controlled trial in this field included 1250 participants with stroke. 10 No differences in patient outcomes were found. However, rather than augmenting services, that trial studied task shifting 11 of stroke rehabilitation to family, as most patients had no access to postdischarge services. No randomized controlled trials have investigated family-assisted therapy to augment physiotherapy for older adults with multimorbidity, nor have there been trials focused on outcomes specifically relevant to this group such as the prevention of falls.
There is concern that involving family in delivering therapy for older people may be unsafe and burdensome. A qualitative study involving patients, family members, a hospital consumer group and physiotherapists associated with a transitional care programme reported positive aspects to family involvement. 12 Yet patients and physiotherapists were concerned about increasing caregiver burden, and physiotherapists and consumers were mindful of safety. Trials investigating this approach for people after stroke found no increase in adverse events including falls and no increase in caregiver burden. 9, 10 However, these risks are important for older people with multimorbidity 3, 13 and need consideration.
Therefore, the aim of this pilot randomized controlled trial was to investigate family-assisted therapy to augment physiotherapy for older people transitioning from hospital to the community, to inform a future, fully powered trial. Our primary objective was to explore the effects of the intervention on falls and falls-related self-efficacy. The secondary objective was to determine the effect on clinical outcomes and impact on family members.
Methods
A pilot randomized controlled trial was conducted with two parallel groups and 1:1 allocation. Participants were recruited from December 2016 until June 2018. Follow-up was completed by September 2018. An experimental group receiving family-assisted therapy in addition to usual physiotherapy care was compared with a control group receiving usual physiotherapy care only. The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry (ID number ACTRN12616000565448) and approved by the Austin Health Human Research Ethics Committee (HREC/16/AUSTIN/502) and the university ethics committee. All participants provided written, informed consent.
Participants were patients and family members of patients admitted to the Transition Care Program at a metropolitan health service in Melbourne, Australia. To differentiate between these two groups of participants, we will refer to them as 'patients' and 'family members', respectively, in this article. The Transition Care Program included 72 residential beds in hospitals and nursing homes. Patients in this publicly funded programme have access to nursing and personal care, case management and allied health services in a residential bed or at home, for up to 12 weeks. Patients in Transition Care who may have been eligible were provided with written information by clinicians and flagged to the research team who then assessed for eligibility and offered the opportunity to consent.
To be eligible for inclusion in the trial, patients had to be admitted to residential Transition Care at the time of recruitment. They had to be able to follow single-stage commands and to stand with the assistance of no more than one person, to enable family members to safely help with functional exercises. Basic English comprehension, as evaluated by the ability to participate in basic conversation about the trial, was required. Patients were not excluded due to impaired cognition. The presence of cognitive impairment was documented if recorded in the medical record. Patients were also required to have a willing, eligible family member or friend available to assist with the intervention.
Eligible family members were aged 18 years or older, available to assist with therapy at least three times weekly, physically fit as assessed by selfreport, and able to comprehend English language. Patients were permitted to invite more than one family member to participate.
Randomly permuted blocks of four and six were generated by a researcher not involved in recruitment, the intervention or data collection, using an on-line programme (http://www.randomization. com). The same researcher then prepared sequentially numbered, opaque envelopes for group allocation. Participants were enrolled by another researcher and assigned to interventions by opening the next envelope in the sequence.
Patients allocated to the control group received usual-care physiotherapy from clinicians in Transition Care. Usual-care interventions included mobility training, exercise, caregiver training and discharge planning provided by a physiotherapist or allied health assistant at an average frequency of two sessions per week (sessions could be of variable duration). 7 The experimental group participated in familyassisted therapy, in addition to usual care. Familyassisted therapy was tailored to patient goals and family members were encouraged to conduct at least four therapy sessions per week of a length that fitted the participants' preference. Family-assisted therapy included transfer practice, walking or simple exercises considered safe for the family member to assist with. 12 Family members were offered 60 minute faceto-face appointments at least weekly over four weeks, with a member of the research team who was a physiotherapist with 15 years of experience in rehabilitation for older people, to learn how to provide the intervention and for the physiotherapist to monitor progress. Exercises were documented on an exercise sheet and falls/exercise diary (Supplemental Appendix 1). Appointments were generally during business hours Monday to Friday, unless otherwise requested by family members. Participants also received contact via telephone, email or text message to provide support, monitor progress and answer questions.
Outcomes (self-reported questionnaires and physical activity monitoring) were measured at the beginning and end of the intervention (Week 0 and Week 5). Baseline measures were completed prior to randomization. Follow-up self-reported questionnaires were completed by the participants without assistance unless required. Physical activity and questionnaire data were entered by a researcher blind to group allocation.
The primary outcomes were falls-related selfefficacy (self-report measure) and the number of falls from baseline to the end of the intervention period (direct measure) expressed as a risk ratio and incidence rate ratio. Falls-related self-efficacy was measured by the Short Falls Efficacy ScaleInternational, a valid and reliable patient-reported scale on concern about falling when participating in daily activities. 14 A score of zero indicates no concern and the maximum of 28 indicates severe concern. 14 Participants were asked to record falls on a falls diary and were reminded to complete the diary via email or verbal reminders. Cross-checking of falls information against the hospital incident reporting system and patient medical files was completed to reduce the likelihood of missing data. 15 Secondary outcomes were as follows:
• • Physical activity measured by an accelerometer (activPAL, PAL technologies, Glasgow), which each patient wore for three to nine days for 24 hours per day. The accelerometer measured daily steps and time spent walking, standing, and sitting or lying and has been validated for use with older people. 16 If less than three days of data were available, these data were considered missing and were not included in analyses. • • Health-related quality of life measured using the EQ-5D-3L (three-level version of the EuroQoL five-dimensional health-related quality of life questionnaire). The visual analogue scale component is measured from 0 to 100 with 100 indicating higher health-related quality of life. The index ranges from 0 to 1, with 1 indicating higher health-related quality of life. This measure has been used in Transition Care. 17 To gain a preliminary understanding of the effect of the intervention on clinical outcomes, a sample size sufficient to detect a large, clinically significant between-group difference in fallsrelated self-efficacy of almost 6 units in older adults, 14 assuming an effect size of 1.0, at a power of 0.8 and an alpha level of 0.05, was sought. It was calculated that a sample size of 34 (17 patients in each group) would be adequate. The minimal clinically important difference for the Short Falls Efficacy Scale -International has not been reported but was estimated to be 3 units, based on half a standard deviation of mean scores 21 reported by adults over 80. 14 Means were compared between the experimental and control groups at Week 5 with analysis of covariance (ANCOVA) using baseline values as covariates (IBM SPSS version 24 statistical software). 22 Standardized mean differences were calculated from change scores from Week 0 to Week 5, divided by the standard deviation of the difference scores. Standardized mean differences, otherwise known as effect sizes, were regarded as small at 0.2, moderate at 0.5 and large at 0.8. 23 The relative risk ratio was calculated for patients who had one or more falls between Week 0 and Week 5. The incidence rate ratio, based on negative binomial regression, was calculated for falls events between Week 0 and Week 5 (StataCorp STATA version 12 statistical software). EQ-5D-3L indices were calculated using Australian weights 24 and ICECAP-O using a general population algorithm developed in Great Britain. 25 Consistent with the principle of intention to treat, all available data were analysed according to group allocation, without regard to level of adherence. The trial was conducted in accordance with the registered trial protocol.
Results
Thirty-five patients and 40 family members consented to participate; 17 patients and 20 of their family members were allocated to receive familyassisted therapy in addition to usual-care physiotherapy, and 18 patients and 20 of their family members were allocated to receive usual-care physiotherapy only (Figure 1) . One patient was recruited in addition to the planned sample size as two were offered the final place in the trial and both consented. All patients received their intervention as allocated. Week 1 of the trial was an average of 23 days (SD = 17.4) after admission to Transition Care and Week 5 an average 11 days (SD = 31.9) before discharge.
The two groups were similar regarding age, gender, diagnosis, comorbidities and assistance required to stand or walk. Family members in the experimental group were younger than in the control group, with more retirees in the control group (n = 8) ( Table 1) .
Compliance with trial method
Patients in the experimental group received an average of four family-assisted therapy sessions per week (Table 2 ). Therapy goals expressed by patients included improving functional mobility (n = 10), increasing leg strength (n = 2), community participation (n = 3) and building confidence (n = 2). Families received training about exercise prescription, mobility retraining, monitoring of pain and fatigue, benefits of physical activity, and walking programmes. One family member in the experimental group did not conduct any exercise sessions due to conflicting family responsibilities. Other reported reasons for missed sessions planned by family members included patient illness or appointments, family member commitments and the weather. Treating physiotherapists reported some patients in the control group received walking assistance from their families, but specific data on what patients in the control group received were not collected. No serious adverse events were reported, and no falls occurred during family-assisted therapy sessions. One patient sustained a 1 mm skin tear on removal of an accelerometer in Week 0 that resolved without further action. This patient did not have an accelerometer fitted at Week 5. Three patients did not have accelerometers fitted due to concerns about their skin integrity. Accelerometers were worn for a median of five days in Weeks 0 and 5. One accelerometer malfunctioned in Week 0 and only recorded two days of data and another patient in Week 5 removed the monitor after two days. There were a small number of missing data for patient-reported outcome measures. The number of participants included in each analysis is detailed in Table 3 .
Effect of intervention
There were no significant between-group differences for the primary outcome measures. Two of 16 patients (13%) in the experimental group fell one or more times during the intervention period compared to 6 of 18 patients (33%) in the control group, resulting in a relative risk of 0.38 (95% confidence interval (CI) = 0.09-1.60, P = 0.19). The experimental group had an observed falls rate of 78% less than the control group (incidence rate ratio = 0.22, 95% CI = 0.04-1.20, P = 0.08) that approached but did not reach statistical significance. The between-group difference for Short Falls Efficacy ScaleInternational scores was -0.7 units (95% CI = -3.0 to 1.7) with a small effect size of 0.2 observed in favour of the experimental group (Table 3) .
Patients in the experimental group doubled their daily steps, walking an average of 944 daily steps more than those in the control group (95% CI = 139-1748). There were no significant between-group differences for other measures of physical activity although small to large effect sizes favouring the experimental group were observed (Table 3 ). There was no significant between-group difference for health-related quality of life or capability-related quality of life (Table 3) . There was also no between-group difference for the Modified Caregiver Strain Index, with an observed change of -1.2 (95% CI = -3.6 to 1.2) and a moderate effect size of 0.6 observed in favour of the experimental group.
Change in activity limitation (the Modified Barthel Index) favoured the experimental group with a mean between-group difference of 21.5 points (95% CI = 0.8-42.2, P = 0.04). There was no between-group difference for discharge destination (relative risk ratio of nursing home admission for 
Discussion
Our findings suggest family-assisted therapy to augment physiotherapy for older people transitioning from hospital to the community may be safe and improve clinical outcomes. A phase III randomized controlled trial is indicated. The experimental group were observed to have a lower falls rate than the group receiving usual care only. The incidence rate ratio was of borderline statistical significance (P = 0.08) in favour of the experimental group, an inconclusive result which suggests the intervention may be effective with the effect size maintained in a larger trial. 26 Patients in the experimental group also walked almost twice the daily steps than those who did not receive the intervention and had a significant reduction in activity limitation. It is likely these results were achieved alongside a moderate reduction in caregiver strain. 26 No between-group difference was found for health-related or capability-related quality of life. If the effects found of this trial were maintained in a larger, fully powered study, it would result in significant benefits for older people transitioning from hospital to the community. The weaknesses of this pilot study could be overcome in a future, definitive trial. Lack of follow-up was a major limitation as positive results may not have been maintained beyond the end of the four-week intervention period. However, this study demonstrated in a group of older adults with multimorbidity, a four-week trial is feasible, given the low drop-out rate and a recruitment rate of 43%, only slightly lower that the mean recruitment rate of 51% described in a systematic review of recruitment rates of trials involving patient and caregiver dyads. 27 The sample had low representation of culturally and linguistically diverse groups which may limit generalizability if maintained in a larger trial. A cost-effectiveness analysis was not conducted and would be important to include alongside a future trial to estimate the sustainability of this approach. Data about usual care were not collected, but there is no expectation that this would have changed because of the intervention.
Strengths of this trial include its randomized design reducing the risk of bias. 28 Results were reported according to CONSORT guidelines for randomized pilot and feasibility trials. 29 Statistically significant results were attained as well as estimates of effect size that inform a future study. The trial protocol was adhered to, with the intervention resulting in 15 additional therapy sessions for the experimental group, totalling an average of 226 minutes over the four-week study period. In an environment where treatment sessions are often limited to two sessions per week, 7 this represents a substantial increase in therapy.
This trial counters concerns that family-assisted therapy will result in adverse events such as falls and caregiver burden. Previous research indicates physiotherapists can be hesitant to involve families in therapy for this reason. 12 There were no adverse events related to the intervention, with results suggesting a possible reduction in falls and caregiver strain, supporting the notion this approach is likely safe and not burdensome for family members. This outcome is consistent with results from other trials investigating family-assisted therapy after stroke. 9, 10 Perhaps this is attributable to the training and support provided. Patients in the experimental group also took a mean of 944 more daily steps (95% CI = 139-1748) which is comparable to findings from a systematic review of 13 physical activity intervention studies with a focus on older adults, showing a weighted increase of 775 steps per day. 30 Although the number of daily steps increased may appear small, the relative increase was large with participants in the experimental group doubling their mean daily step count. Sustained immobility can increase falls 31 and promoting mobility in the hospital setting has been shown to prevent injurious falls. 32 Risk associated with immobility may be more significant than risk associated with family-assisted therapy.
There was no between-group difference observed for falls-related self-efficacy, a primary outcome for this trial. The intervention is likely ineffective for this outcome since the minimal clinically important difference is 3 units and this is the lower estimate of our CI range. The primarily physical nature of the intervention may account for the lack of change in falls-related self-efficacy. Instead, a behavioural intervention may be expected to address this outcome more directly. Motivational interviewing has been shown to improve falls-related self-efficacy in people approximately six months after hip fracture 33 of similar age to participants in this trial. Alternatively, the Berg Balance Scale 34 may be an appropriate measure, having detected positive changes in other family-assisted therapy trials 35, 36 and being validated for use with older adults. 34 A future definitive trial would require a sample size of n = 138 (69 patients allocated to experimental and 69 allocated to the control group) to detect clinically important change (standardized mean difference ⩾ 0.5) in activity limitation, daily steps, caregiver strain, falls, balance and health-related quality of life, at a power of 0.8 and an alpha level of 0.05. A future trial would require resources so that people from culturally and linguistically diverse backgrounds could be included, to improve the generalizability of findings. Follow-up at three and six months postintervention would help determine the sustainability of postintervention effects. Hospital readmissions could also be measured, which could contribute to a health economic analysis, along with quality of life, length of stay and functional independence measures.
The results of this pilot randomized controlled trial conducted in a Transition Care setting indicate that training and supporting families to assist with physiotherapy is likely safe, effective in improving daily steps and reducing activity limitation, and may lead to a reduction in falls without increasing caregiver strain. A phase III randomized controlled trial could help confirm these preliminary findings.
Clinical messages
• • Family-assisted therapy is likely to be a safe intervention for older people transitioning from hospital to the community and their families. • • Physiotherapy augmented by familyassisted therapy increased daily steps taken, reduced activity limitation and may have reduced falls without increasing caregiver strain.
